Recombinant CD55 anticorps
Aperçu rapide pour Recombinant CD55 anticorps (ABIN7127406)
Antigène
Voir toutes CD55 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human CD55
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Autre désignation
- CD55
-
Sujet
-
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.
Aliases: Complement decay-accelerating factor (CD antigen CD55), CD55, CR DAF
-
UniProt
- P08174
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity
Antigène
-